Increased prescribing trends of paediatric psychotropic medications

I C K Wong1, M L Murray, D Camilleri-Novak

  • 1Centre for Paediatric Pharmacy Research, The School of Pharmacy and the Institute of Child Health, University of London, 29-39 Brunswick Square, London WC1N 1AX, UK. ian.wong@ulsop.ac.uk

Insights

Psychotropic medication prescriptions for children are rising globally. Between 2000 and 2002, seven of nine studied countries saw significant increases, with the UK experiencing the largest growth at 68%.

Area of Science:

  • Pediatric pharmacology
  • Global health trends

Background:

  • Childhood psychotropic medication use has notably increased.
  • Understanding international prescribing patterns is crucial.

Purpose of the Study:

  • To analyze psychotropic prescribing trends in children across nine countries.
  • To compare trends between 2000 and 2002.

Main Methods:

  • Utilized IMS MIDAS Prescribing Insights data.
  • Examined pediatric psychotropic prescription data.
  • Analyzed trends from 2000 to 2002.

Main Results:

  • Significant upward trends in psychotropic prescribing were observed in seven out of nine countries.
  • The United Kingdom exhibited the most substantial increase, at 68%.
  • Prescribing data from 2000-2002 revealed a widespread rise.

Conclusions:

  • Global psychotropic prescribing for pediatric populations shows an increasing trend.
  • The UK experienced a particularly sharp rise in pediatric psychotropic prescriptions during the study period.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...